Foresight Global Investors, Inc. Novartis Ag Transaction History
Foresight Global Investors, Inc.
- $137 Billion
- Q4 2024
A detailed history of Foresight Global Investors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Foresight Global Investors, Inc. holds 232,366 shares of NVS stock, worth $25.4 Million. This represents 16.52% of its overall portfolio holdings.
Number of Shares
232,366
Previous 224,816
3.36%
Holding current value
$25.4 Million
Previous $25.9 Billion
12.56%
% of portfolio
16.52%
Previous 14.03%
Shares
6 transactions
Others Institutions Holding NVS
# of Institutions
1,474Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.34 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.21 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$895 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$751 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$610 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $235B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...